Clinical Trials Browser

Phase 3 × Carcinoma, Hepatocellular × Interferon-alpha × Clear all

NCT01681446 2018-06-01

Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 Expression

Phase 3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular